Teva launches cash and shares bid for Mylan

By

Sharecast News | 21 Apr, 2015

Teva Pharmaceuticals has announced a cash and shares bid for US rival Mylan at $82 per share.

--More to follow--

Last news

US close: Stocks drop as investors scale back risk appetite
London close: Stocks mixed as oil prices continue rising
Director dealings: Gfinity CEO ups stake
FTSE 100 movers: Oil giants gush higher, NatWest jumps
US open: Stocks lower as investors look ahead to Q3 earnings